Your browser doesn't support javascript.
loading
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor.
Fenwick, Craig; Amad, Ma'an; Bailey, Murray D; Bethell, Richard; Bös, Michael; Bonneau, Pierre; Cordingley, Michael; Coulombe, René; Duan, Jianmin; Edwards, Paul; Fader, Lee D; Faucher, Anne-Marie; Garneau, Michel; Jakalian, Araz; Kawai, Stephen; Lamorte, Louie; LaPlante, Steven; Luo, Laibin; Mason, Steve; Poupart, Marc-André; Rioux, Nathalie; Schroeder, Patricia; Simoneau, Bruno; Tremblay, Sonia; Tsantrizos, Youla; Witvrouw, Myriam; Yoakim, Christiane.
Afiliación
  • Fenwick C; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada Craig.Fenwick@chuv.ch lee.fader@boehringer-ingelheim.com.
  • Amad M; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Bailey MD; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Bethell R; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Bös M; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Bonneau P; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Cordingley M; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Coulombe R; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Duan J; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Edwards P; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Fader LD; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada Craig.Fenwick@chuv.ch lee.fader@boehringer-ingelheim.com.
  • Faucher AM; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Garneau M; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Jakalian A; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Kawai S; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Lamorte L; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • LaPlante S; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Luo L; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Mason S; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Poupart MA; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Rioux N; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Schroeder P; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Simoneau B; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Tremblay S; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Tsantrizos Y; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Witvrouw M; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
  • Yoakim C; Biological Sciences and Chemistry Departments, Boehringer Ingelheim (Canada) Ltd., Research and Development, Laval, QC, Canada.
Antimicrob Agents Chemother ; 58(6): 3233-44, 2014 Jun.
Article en En | MEDLINE | ID: mdl-24663024
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: VIH-1 / Inhibidores de Integrasa VIH Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: VIH-1 / Inhibidores de Integrasa VIH Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos